Dr Lennard Lee (Oxford University) Profile picture
Oct 13, 2022 19 tweets 14 min read Read on X
1/x 🧵***New data *** A double🧦 Lancet headline paper @TheCrick in London from @stcshepherd @TurajlicLab @DavidLVBauer. Results are ASTONISHING about whether we need to protect the #immunocompromised #forgotten500k. thelancet.com/journals/lance… & thelancet.com/journals/lance…. Pls RT.
2/x For those who you don't know. @TheCrick is one of our UK's leading research 👩‍🔬💪heavy weights with some of the best scientists in the country like @stcshepherd @TurajlicLab @DavidLVBauer. For them to be weighing into the national pandemic landscape is timely & important
3/x. Paper 1⃣ asked the question about cancer patients. They are very #immunocompromised, especially @bloodcancer_uk patients. @stcshepherd @TurajlicLab assessed ~200 cancer patients from their study and looked at immune response to omicron. A study and measure of "protection".
4/x Complex figure now. This is a violin plot as scientist say blue shapes look like violin. If violins are lifted up it's good. If they're low it is bad. It says post vaccines, 56% of @bloodcancer_uk have some neutralisation (protection against omicron), 44% do not. Not great.
5/x. What have @thecrick & @stcshepherd said about @bloodcancer_uk & coronavirus? 👇. i.e. further evidence that in patients who are immunocompromised, and more protection is required beyond vaccination. 🫢. Next paper answers "what might this be?" (no surprises). Paper 2 is good
6/x. Paper 2⃣ thread here . It asks does antibody therapy work? specifically #Sotrovimab and #evusheld. Important as it is another petri dish assay, but this time showing exciting findings. 🐛🪲🐞 They call their work ***URGENT***🧐. It 💯% is.
7/x. It was a lab petri-dish test- neutralising assays. How likely was antibody therapy to work. He's a very candid and honest scientist 👇. To date drugs like #evusheld and #sotrovimab work well in humans, but don't seem to work in a petri dish.
8/x. Why does he call his work ***URGENT***🧐? Because many countries are making irregular decisions based on neutralising petri-dish assays, like stopping patients get good treatment like #sotrovimab, or in the case of #evusheld not buying it at all (UK solely).
9/x. Results now and they are very colourful (though still easy to interpret). Flat lines= don't work, Downward waves=neutralises + works. Each result repeated 3 times, 12 times for certainty. The lines for Sotrovimab and Evusheld have shifted. They STILL WORK with higher dose👇
10/x. Intriguingly, the authors hold no punches here. There is one argument "that the only way to show treatment works when a new variant comes is for 50% of patients get a sugar injection- a trial". The BLIND RANDOMISERS argument. Here's what he says-👇
11/x. What's my take? COVID cases are surging, up by 50% in the last month and continuing to rise. For most it will be a mild disease, but if you don't have an immune response or are #immunocompromised, this can't be guaranteed. The crisis of #forgotten500k is now widely known
12/x. There are half a million immunocompromised people in the UK. Many are still shielding, still in isolation, still unable to work, see friends or hug loved ones. They are #forgotten500k, unheard & calling on us to notice. They are at higher risk of being hospitalised & more.
13/x. 32 countries are delivering additional levels of protection this winter to protect immunocompromised patients who have not responded to the coronavirus vaccine, using new therapies, not available in the UK- prophylactic antibody therapies with #evusheld
14/x. Their only protection if infected, #sotrovimab might be removed too. There is no urgency regarding the absence of #evusheld access this Winter. To give an “immune” system and "level up" protection compared to the population. UK patients have to wait till next summer.
15/x. @TheCrick has weighed into the debate providing timely science confirming what the world knows globally. We should be protecting the immunocompromised in the UK with the best antibody therapies and everyone is now asking for it to happen before soon- before Christmas.
16/x The UK clinical community has also sprung into action. Patients, 125 clinicians from 17 medical specialities & 4 nations are now online with 19 charities and patient groups. And so many MPs like @libdemdaisy who rallied so many MPs who are hearing first hand the mental and
17/x. physical health impact of delayed decision making that is not yet "up to date" with science. I expect that's natural, when science moves fast 🏎️. However, with all the evidence presented, all showing the same thing, will the UK move fast once again or remain indifferent? 🤷
18/x. Thanks must go to both groups for "TOUR DE FORCE" papers. From one of the leading UK research institutions. Thoroughly brilliant research demonstrating 1⃣ the issue & 2⃣ solutions served on a plate🍽️. Let's hope there is action + compromise in the run up to Xmas 🎄🤶.
19/x. My thoughts are with our #immunocompromised patients. Thank you to supporters. Tens of thousands of people are backing #forgotten500k campaign for their Winter plan and call for more protection for the #immunocompromised. Hopefully authors might answer Qs 🤞.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Dr Lennard Lee (Oxford University)

Dr Lennard Lee (Oxford University) Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @drlennardlee

May 16
1/x *** New Research ***. 😀What can be done to protect immunocompromised patients? New press release from @AstraZeneca. , and it's about a therapy called Sipavibart, the successor to Evusheld. astrazeneca.com/media-centre/p…
Image
2/x. What is the background? Some individuals in our community are more prone to infections, they are called immunocomromised. There are ~ 500,000-1.5M with these conditions. When they get infections, they can fight it less well. 🙄 And the pandemic hit, this was a problem.
3/x It includes renal transplant patients, primary immunodeficiencies, those with cancer & blood cancers, kidney disease, and those with primary immunodeficiencies. It's a fair number. Most doctors want to protect these patients from infectious diseases by what ever means 😇
Read 11 tweets
Jul 25, 2023
1/x 🧵 ***NEW RESEARCH *** How has #COVID-19 disease evolved in people living with #cancer and who remains at risk? Find out more in our latest publication from @UKCORONACANCER: https://t.co/P9NdBtbCRWnature.com/articles/s4159…
Image
2/x It is relevant as healthcare systems develop strategies for living with SARS-CoV-2 as an endemic disease and informing individual discussions between cancer patients and their oncologists. And to ensure that no one is left behind or forgotten. Image
3/x What was done? They analysed COVID-19 infections in the 🏴󠁧󠁢󠁥󠁮󠁧󠁿 population, assessing rates of COVID-19 related hospitalisation, intensive care admission and mortality. It ran Winter 20-Summer 22 Image
Read 11 tweets
May 21, 2023
1/x #Cancercapacitychallenge @FinancialTimes V. Relevant #cancer. It's interesting with good & also worrying stories.... 😀☹️ From UK professionals @RCRradiologists @BOPACommittee @ACPUK @UKONSmember ft.com/content/b22e21… 👇RT if agree ImageImageImage
2/x What's the issue ? The UK delivers successful cancer care. Year on year, people live longer and better lives. gov.uk/government/new…. 10% improved survival in 15 years. That is by achieved early diagnosis, having better treatment the best cancer staff, research. 😀🏆🇬🇧✊ ImageImage
3/x but.... there's a flipside. Our Cancer leadership quote "Demand for cancer treatment is increasing by approximately 6-8% every year" and "They are being asked to deliver more treatment with the same staffing numbers"
Read 12 tweets
Jan 22, 2023
1/x 🧵This Friday at 10:30am, we're excited to announce the reboot of the #forgotten500K campaign with an update from the podcasts hosted by @claremenglish, @MarkOak04974342, @NikolaBrigden. Here's the message for 2023 in advance. RT. 👇
2/x "The #forgotten500K are a group of immunocompromised patients who have not been prioritized during the pandemic and are experiencing higher ongoing levels of risk. The group started off as individuals asking for help while still in isolation during the pandemic.
3/x They were speaking as individuals trying their best to be heard virtually, as they were not able to leave their homes and re-enter normal life like everyone else. However, the #forgotten500K patient campaign brought them together, providing support and one voice. amazing
Read 18 tweets
Oct 29, 2022
1/x Several months ago, @katebingham2 drove the UK pandemic response. She is incredible 🦸‍♀️- thanks for your insight. But then she finished and something extraordinary happened. The Winter plan to protect the #immunocompromised was quietly dropped....😫 Why does it matter? 🤷🤷‍♂️🤷‍♀️
2/x Because it had widespread clinical & academic backing for our 2022 Winter plan. Cohorts were identified & large teams of clinicians worked around the clock to work out which of #immunocompromised who don't have high levels of protection from vaccination could be protected 👩‍⚕️ Image
3/x This would have put us in line with 32 countries who were protected their #immunocompromised during the Winter months when COVID cases rise. If you don't respond to vaccines 💉, then your risk of hospitalisation, ITU admission & not recovering from COVID is 📈 Image
Read 11 tweets
Oct 26, 2022
1/x 🧵 ***NEW RESEARCH 👨‍🔬 *** About #immunocompromised #forgotten500k #cancer. It's a BIG paper, analysing the global data 🗺️. Answers the question- how big is the issue of absent immune responses following covid vaccines. @BrJCancer by @michaeltilby nature.com/articles/s4141… 💛💚
2/x Why did they do it? Because 1⃣ cancer patients are at high risk from covid 📈 2⃣ Many don't get an immune response to vaccines 💉 3⃣ They wanted to find the scale of the problem 💥. So they decided to go global! 🌐
3/x. The team searched 3065 papers published from the start of vaccination to March 2022. They looked at third dose boosters 💉. They looked across all cancer types. They found 15 studies encompassing 1205 patients🧑‍🤝‍🧑. The largest global review 🌍
Read 11 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(